• Aucun résultat trouvé

Patient-Reported Outcomes (PRO)

Power and Sample Size Determination for the Group Comparison of Patient-Reported Outcomes with Rasch Family Models

Power and Sample Size Determination for the Group Comparison of Patient-Reported Outcomes with Rasch Family Models

... For now, the main limitation of the Cramer-Rao method is that the variance can only be estimated in the frame of Patient- Reported Outcomes evaluated with dichotomous items in a cross- sectional ...

14

Synthèse de la littérature sur les Patient-Reported Outcomes  (2010-2019)

Synthèse de la littérature sur les Patient-Reported Outcomes (2010-2019)

... Le think tank FasterCures mène une réflexion sur le design des PRO, et a notamment proposé, en 2017, un workshop intitulé : « Patient-Reported Outcomes: Design with the End in Mind » (Grossman, ...

24

Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters

Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters

... Myriam Blanchin * , Alice Guilleux, Bastien Perrot, Angélique Bonnaud-Antignac, Jean-Benoit Hardouin and Véronique Sébille Abstract Background: Patient-reported outcomes (PRO) are important as ...

13

Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients--a simulation study.

Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients--a simulation study.

... Methods coming from modern measurement theory, such as IRT models, might provide a powerful frame- work to build and reduce PRO instruments and analyse such data in an efficient and reliable manner and should provide ...

11

Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

... Patient-reported outcomes Patients showed high levels of adherence to both antiretro- viral and HCV treatments during follow-up (Table ...symptoms reported at the end of HCV treatment (EOT) ...

12

Prescription and efficacy of daclatasvir and sofosbuvir +/- ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: the CMPASS-EU cohort study.

Prescription and efficacy of daclatasvir and sofosbuvir +/- ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: the CMPASS-EU cohort study.

... in patient-reported outcomes in this more clinically advanced group were not statistically significant at month 3, but became so thereafter and subsequently matched or exceeded improvements in the ...

16

Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results from NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination with Tenofovir/Emtricitabine or Raltegravir

Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results from NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination with Tenofovir/Emtricitabine or Raltegravir

... Patient-reported outcomes PROs were collected at baseline and during scheduled follow up visits at weeks 4, 12, 24, 48 and 96 through self-administered questionnaires in participants’ native ...

25

Synthesis of the literature on patient-reported outcomes (2010-2019)

Synthesis of the literature on patient-reported outcomes (2010-2019)

... of patient-reported outcomes (PROs), a term we use to refer to both health outcomes reported directly by patients, and the tools used for their collection and ...measure patient ...

22

Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study.

Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study.

... throughout the study compared with those observed for clinical outcomes [22]. There are a number of potential explanations for this. For example, PROs require the pa- tient to complete questionnaires, and this ...

15

View of Continuous Quality Improvement in Orthopaedic Surgery: Improving Patient Experience, Safety and Outcomes

View of Continuous Quality Improvement in Orthopaedic Surgery: Improving Patient Experience, Safety and Outcomes

... better patient satisfaction, improved patient-reported outcomes, highly-efficient care pathways, and overall ...improving patient experience, and ...of patient care in North ...

11

Understanding patient outcomes to develop a multimorbidity adapted patient-reported outcomes measure: a qualitative description of patient and provider perspectives

Understanding patient outcomes to develop a multimorbidity adapted patient-reported outcomes measure: a qualitative description of patient and provider perspectives

... the patient-centered care ori- entations set out by the Québec government’s depart- ment of health concerning the management of people with chronic conditions, ...support, patient-centred care, motivational ...

8

Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study

Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study

... ment period as long as the patient was receiving benefit from trifluridine/tipiracil and no adverse events leading to dose reduction occurred. Dose adjustments and dose delays were based on individual safety and ...

11

A methodological review of clinical outcomes reported in liver transplantation trials

A methodological review of clinical outcomes reported in liver transplantation trials

... recovery outcomes), as well as heterogeneity in the timeframe of outcome assessment were evident ...that patient-reported outcomes were very seldom reported and never as primary ...some ...

36

The Patient-Reported Experience Measure for Improving qUality of care in Mental health (PREMIUM) project in France: study protocol for the development and implementation strategy

The Patient-Reported Experience Measure for Improving qUality of care in Mental health (PREMIUM) project in France: study protocol for the development and implementation strategy

... assessing patient-reported experience of mental health ...the patient-reported outcomes measurement information system 115 and the International Consortium for Health Outcomes ...

14

Potential Patient-Reported Toxicities With Disulfiram Treatment in Late Disseminated Lyme Disease

Potential Patient-Reported Toxicities With Disulfiram Treatment in Late Disseminated Lyme Disease

... Lyme patient organizations, MDs and PhDs, has recently been alerted to severe and persistent toxic events in a patient suffering from a late disseminated form of Lyme Disease following disulfiram ...

8

A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy

A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy

... Patient-reported outcomes A B S T R A C T Objective: This study aimed to evaluate safety and efficacy of sodium oxybate (SXB) titrated to effect. Methods: SXB-naive patients who had participated in a ...

7

View of Genetics and Medicine Collaborative Effort: Can targeted genetic testing aid in early disease detection and improve patient outcomes?

View of Genetics and Medicine Collaborative Effort: Can targeted genetic testing aid in early disease detection and improve patient outcomes?

... If a child has a family history which includes a hereditary condition, it should prompt the physician to refer the presupposed patient, to a geneticist specialist. Increased awareness of the patient’s family ...

5

Is Self-Reported Risk Aversion Time Varying?

Is Self-Reported Risk Aversion Time Varying?

... We examine a Japanese Panel Survey in order to check whether self-reported risk aversion varies over time. In most panels, risk attitude variables are collected only once (found in only one survey wave), and it is ...

46

Reported Job Satisfaction : What Does It Mean?

Reported Job Satisfaction : What Does It Mean?

... that reported job satisfaction has two components, one of which is backward-looking and known with certainty, and the other is forward-looking and based on a personal ...of reported satisfaction or ...

40

Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)

Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)

... the patient perspective through a holistic approach and utilizing a questionnaire designed for patients, with ...was patient reported, and there- fore, information relating to the time period ...

10

Show all 1857 documents...

Sujets connexes